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Summary.-Intracellular fluorescence polarization (IFP) values of normal human
lymphocytes and leukaemic cells from newly diagnosed patients were determined
from fluorescence polarization using fluorescein diacetate (FDA). Thirty healthy
donors and 40 patients with various types of leukaemia (20 myelogenous and 20
lymphocytic) were included in the present studies. The result was that myeloid cells
had about twice the polarization value of lymphocytic cells. The use of FDA for the
determination of IFP appears to be useful for differential diagnosis, at least between
acute myelogenous and lymphocytic leukaemias. These 2 types of leukaemia also
showed a pronounced difference in fluorescence intensity when treated with FDA,
perhaps owing to a difference in uptake velocity. The previously described membrane
microviscosity using 1,6-diphenyl-1,3,5-hexatriene (DPH), however, did not show
such a difference between these 2 leukaemias.
The fluorescein-binding protein(s) was also investigated in order to clarify its
effect on IFP, but there seemed little evidence for the existence of any such dye-
binding protein(s). The advantages of the present method, using FDA, reside in its
simplicity, rapidity and considerable sensitivity, requiring a small sample of blood
usually <5 ml.
A PRECISE DIAGNOSIS and classification
of leukaemia play a critical role in the
choice of treatment regimes. A prompt
differential diagnosis of acute myelo-
genous leukaemia (AML) and acute lym-
phoblastic leukaemia (ALL), and that of
myeloblastic and lymphoblastic crises of
chronic myelogenous leukaemia (CML)
are particularly important, since their
responses to drugs and prognoses are
greatly different (Clarkson et al., 1975;
Body & Rodriguez, 1978; Rosenthal et al.,
1.977; Forman et al., 1977). Morphological
differentiation alone is insufficient for
exact classification (Bennet et al., 1976),
because leukaemic cells are frequently so
bizarre or atypical in appearance that
morphological categorization is not always
objective or precise. Alternatively, various
biochemical and immunological techniques
have been established and utilized for cell
classification (Greaves & Janossy, 1978).
More recently, flow cytometry was intro-
duced for this purpose (Andreeff et al.,
1980). So far, however, any such single
method alone is inadequate for a definite
classification or evaluation of prognosis,
and the combined use of a number oftests
is essential in some difficult cases. Thus,
simpler and more reliable methods will be
useful for such purposes.
Fluorescence-polarization techniques
have been used to determine membrane
microviscosity (Shinitzky & Inbar, 1976)
or structuredness of cytoplasmic matrix
(SCM, or cytoplasmic fluidity) of living
cells (Cercek & Cercek, 1977). For the
determination of membrane microvis-
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cosity, fluorescent lipophilic probe, 1,6-
diphenyl-1,3,5-hexatriene (DPH), hasbeen
used (Shinitzky & Inbar, 1976) though
DPH is also known to bind to internal
membranes and lipid droplets in the cell
(Collard & DeWildt, 1978). For the
cytoplasmic probe a fluorogenic re-
agent, fluorescein diacetate (FDA), non-
fluorescent by itself, is used (Rotman &
Papermaster, 1966). FDA is unique in that
it is taken up only by viable cells, and is
subsequently hydrolysed by intracellular
esterases to yield fluorescent fluorescein
as described by Rotman and Papermaster
(1966) and the degree of fluorescence
polarization (P) of fluorescein can be
readily determined (e.g. Cercek & Cercek,
1977).
In this study we measured P values of
various types of purified leukaemic cells
from freshly diagnosed leukaemic patients,
using DPH and FDA. Furthermore, the
fluorescence intensity due to uptake of
FDA was also determined simultaneously.
The present data appear to be useful for a
differential diagnosis of lymphocytic and
myelogenous leukaemia, with simple in-
strumentation, by virtue oftheir markedly
different intracellular fluorescence polar-
ization (IFP).
MATERIALS AND METHODS
Patients-.Blood samples were obtained
from hospitalized and ambulatory patients in
several local hospitals (Table J): 16 patients
with AML, 10 with ALL, 14 with other types
of leukaemia, and 30 normal individuals, all
with donor's consent. Evaluation by the
present method was carried out primarily on
pre-diagnosed or newly diagnosed patients
before any therapy. Evaluations of some
patients were also made at least 3 weeks after
the last drug treatment.
Diagnosis. -Diagnoses were based on
classic clinical and laboratory criteria
(Henderson, 1977), namely the conventional
methods such as morphological and histo-
chemical analysis. Giemsa, peroxidase,
periodic-acid-Schiff (PAS) staining, and
occasionally a-naphthyl acetate-esterase
staining were carried out on peripheral-blood
and marrow smears. In the case of lympho-
cytic leukaemia, 2 major surface markers,
surface immunoglobulin and E-rosette forma-
tion, were examined. A few unclassified
leukaemias were tested for in vitro prolifer-
ative response to various lectins such as
concanavalin A, PHA and pokeweed mitogen.
Cultured cell lines.-P3HR-1 (Hinuma et
al., 1967), Daudi (Klein et al., 1968) and
NC-37 (C-6) (Durr et al., 1970) are Epstein-
Barr virus (EBV)-associated nuclear antigen
(EBNA)-positive lymphoblastoid cell lines,
as previously reported. K/TB was another
EBNA+ cell line established from normal
adult peripheral lymphocytes after trans-
formation by EBV, and cultured for not more
than 2 years. Molt-4, a T-cell leukaemia line,
was established from a CLL patient (Mino-
wada et al., 1972). K-562 was a leukaemic cell
line derived from a patient with CML
(Lozzio & Lozzio, 1973). All transformed cells
used in this study were cultured in RPMI-
1640 medium enriched with 10% foetal calf
serum and used during exponential growth,
and they had a viability of >95%.
Chemicals.-FDA was obtained from Dojin
Chemical Co. Ltd, Kumamoto, Japan. DPH
(Aldrich Chemical Co.), fluorescein and
bovine serum albumin (BSA) were purchased
from Wako Pure Chemical Industries Ltd,
Osaka, Japan. All other chemicals were from
commercial sources.
Separation of mononuclear cells.-Mono-
nuclear cells were separated from fresh
heparinized peripheral blood or marrow
aspirates obtained from patients and healthy
donors by Ficoll-Conray density gradient
centrifugation. They were washed x 3 with
Eagle's minimum essential medium and re-
suspended with RPMI-1640 (both from
Nissui Seiyaku Co. Ltd, Tokyo) supplemented
with 10% foetal calf serum (Grand Island
Biological Co., Grand Island, N.Y.) at a
concentration of 106 cells/ml. The percentage
of leukaemic cells in test samples was based
on a Giemsa-stained film ofeach preparation.
Measurement of P values with DPH.
Labelling of cells with DPH was performed
according to the method described by Inbar
et al. (1974). Briefly, a solution of 2 x 10-3M
DPH in tetrahydrofuran (spectrograde) was
diluted 1000-fold by injection into vigorously
stirred O-O1M phosphate-buffered 0-15M NaCl,
pH 7 0 (PBS). The DPH dispersion was
mixed 1:1 (v/v) with cell suspensions and
incubated for 1 h at 25°C. The labelled cells
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were then washed x 3, resuspended in PBS,
and immediately used for fluorescence
measurement at 370C.
Measurement of intracellular fluorescence
polarization (IFP) value with FDA.-The
cells prepared as described above were incu-
bated for 30 min at 37TC, washed and re-
suspended in PBS at a concentration of
5 x 105 cells/ml. The suspension in 2 ml was
transferred into a cuvette and placed in the
thermostated cuvette holder and held for
more than 5 min at 300C. A stock solution of
FDA was prepared as follows: FDA (20 mg)
was initially dissolved in 1 ml of chloroform
(spectrograde) which was then diluted with
PBS (pH 6.8) under vigorous stirring to give
a concentration of 25 ,uM, and stored frozen
until use. A 50,1I aliquot of FDA stock solu-
tion was added to a cuvette, followed by
thorough mixing (by inverting the cuvette
several times covered with a piece of para-
film). The cuvette was immediately placed in
a thermostated spectropolarimeter at 30TC,
and measurement was started. P values and
fluorescence intensity were obtained auto-
matically in print-outs. Detailed assessment
of these assay conditions will be published
elsewhere.
Instruments.-Polarization spectrofluoro-
metry was performed with a JIMCO polariza-
tion spectrofluorometer Model MAC-2 Type
HR-1 (Japan Immunoresearch Co., Ltd,
Takasaki, Japan). This instrument was
equipped with some novel features, such as a
rotating analyser polarizer which permits use
of only a single photomultiplier, and use of a
high-performance 3-cavity filter, as described
by Maeda (1979) and Maeda et al. (1979). For
the measurement of P values of the fluores-
cein probe, an excitation filter for 490 nm
and an emission filter with band path maxi-
mum at 520 nm were used. For DPH an
excitation filter for 365 nm was used. All
these filters were obtained from Ditric
Optics Inc., Hudson, Mass., U.S.A. For the
emission of DPH, a cut-off filter (an aqueous
solution of IM NaNO2 in a 10mm cuvette
which cuts the wavelength below 390 nm
(Shinitzky & Inbar, 1974)) was used.
A refrigerated water circulator Model
RTE-8 (Neslab Inst. Inc., Portsmoutb, N.H.,
U.S.A.) was used to keep the operating tem-
perature constant within +0.05°C.
The results were expressed as P, which is
standardized to a mean of real P at 10, 15
and 20 min after FDA addition.
FiG.. I -Fluorescence microphotograph of fluorescein diacetate (FDA)-treated lymphoblastoidl cells
(K/TB line). Other leukaemic cells appear similar. Note that fluorescence is observed in the cyto-
plasm, nucleus, microgranules, and to a lesser extent in the cytoplasmic membrane.
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Fluorescence tnicroscopy.-An established
cell line (K/TB) and some leukaemic cells
wvere used to confirm the intracellular location
of the fluorochrome. The cells wNere washed
twice ith PBS and resuspended in PBS
before use. A small drop of cell suspension
as placed on a glass slide, followed bay
subsequent addition of 5 ,ul of FDA stock
solution, and fluorescence microscopy was
then performed at room temperature.
RESULTS
Fluorescence intensity nteasurenent and
microscopy in leukaemic cells
Immediately after the addition of FDA
to the cell suspensions, fluorescence was
apparent in the cytoplasm (including
microgranules and cytosoi) as well as in
the nucleus, but to a lesser extent in the
cytoplasmic membrane, under fluorescence
microscopy (Fig. 1). The fluorescence
intensity became detectable by the instru-
ment after 5-10 min, and continued to
increase for 20-30 min (Fig. 2) and the
cells remained fluorescent for more than
30 min.
Uptake velocity of FDA, which was
calculated from the increased fluorescence
intensity offree fluorescein in a given time,
was generally higher in myeloid than in
lymphoid leukaemic cells, though there
was some variation within each group
(Fig. 2 and 3).
The release of fluorescein from cells
after 30 min was undetectable (< 0
pmol/ml) under our conditions, from the
measured fluorescence intensity of the
supernatant of the cell suspension after
centrifugation (1200 rev/min for 10 min).
Intracellularfluorescence polarization values
of leukaemic cells
The results showed a marked difference
between lymphocytic and myelogenous
leukaemias in P (Table I, Fig. 4); namely,
leukaemic cells from AML had apparently
higher values (P= 0-271 + 0.022, n = 14).
P of 3 subclasses of AML (MI + 2, 3 and
4 by FBA classification; Bennet et al.,
1976) are 0-272+0 023 (n=7), 0-258+
Q300
0200
0.10c
z
z
z
w
I.
0
3
2
10
INCUBATION TIME WITH FDA
20min
Fi'ec. 2.-A typical time course of fluorescence
polarization (A) anid rate of FDA uptake
(B). FDA was added at Time 0 andl botht
values were measured subsequently at
:30oC tunder thiermostatic control. Symbols
indicate leukaemic cells from A.Ml, (Case
No. 25, 0) and ALL (Case No. 5, *) and]
normal peripheral lymphocytes (0).
0 007 (n = 3), 0-278 + 0-029 (n = 4), respec-
tively, with small deviations. Cells from
CML, including acute crisis and a rare
case of chronic neutrophilic leukaeinia,
had a P of 0-261 + 0 016 (n = 4), identical
to that of AML. On the contrary, P for
leukaemic cells of ALL (P = 0 125 + 0.045,
n = I0) were significantly lower than those
of myelogenous leukaemia (P< 0-001) or
mononuclear cells from normal donors
(P=0-187+0X017, n=30) (0X001<P<
0-01). Other types of lymphocytic leu-
kaemic cells, CLL (T, B and Null-cell
types), Waldenstrom's macroglobulin-
aemia, and non-Hodgkin's malignant lym-
phomas, had comparable P to ALL (0.172
+0007; n=3, 04121, n=l and 0-168+
0-040, n=3 respectively), although one
case of adult T-cell leukaemia had rather
a high value (P = 0 205) (Fig. 4).
P of several different cell lines of cul-
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FiG. 3.- Uptake velocity of FDA as mneasured by fluorescence intensity. A andl B are the values for
leukaemic cells of lymphceytic and myelogenous origin respectively. The initial veloeity was
calculated from the time required to reach a fluorescein concentration of 0 1 nM/l. The Xvelocity of
normal peripheral lymphocytes (n = 30) is shown by the dotted area. The circles with numbers
indicate the patients who were subjected to a second measurement ( O). Althouglh these data were
arbitrary expressed as upteke velocity, the esterase activity partially contributes to this activity.
The bars represent the mean + s.d.
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tured lymphoblastoid cells were also
measured. As shown in Fig. 4, their P
values were at the level between lympho-
cytic and myelogenous leukaemias. Inter-
estingly, P for K-562, a myeloid leukaemic
cell line, showed no difference from those
of other lymphoblastoid cell lines of B-
or T-cell origin.
Fluorescence polarization as measured by
DPH in leukaemic cells
The fluorescence polarization values of
DPH-labelled representative leukaemic
cells are shown in Table II. The data
indicate that fluidity of the DPH-bound
lipid components of lymphocytic leu-
kaemic cells (P=0-236+0-017, n=14) is
significantly increased (0 001 <P < 001)
over normal lymphocytes (P =0*251 +
0 001, n= 17). Myelogenous leukaemic
cells had a P of 0-236+0-019 (n=13)
comparable to that of lymphocytic leu-
kaemic cells. However, some of these
leukaemic cells, e.g. CML (P = 0.252 +
0-020, n = 4), had P values close to those of
normal lymphocytes. There seems to be
no significant difference in the membrane
fluidity or DPH-bound lipid components
among different classes of lymphocytic
and myelogenous leukaemia, as measured
by DPH.
DISCUSSION
Various attempts have been made in
recent years to define classes or subclasses
of leukaemias, and to ascertain whether
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FIG. 4. Fluorescence polarization values (P) of various leukaemic cells, in comparison witlh niormal
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TABLE II.-Membranefluidity as revealed by P using DPH
Cells p*
A
0
0 0
.
536I
ALL 0233+0-016(n=6)t
CLL 0-245 + 0-025 (n = 4)
Non-Hodgkin
lymphomas 0-233 + 0 009 (n =4)t
AML 0-229 + 0-014 (n =9)t
CML 0-252 + 0-020 (n =4)
P3HR-1 0-206
C-6 0-206
KT/B 0-216
AMolt-4 0-214
Normal
lymphocytes 0-251 + 0-011 (n = 17)
0-236+0-017 (n= 14)t
}0 236+0 019 (n= 13)t
)0-211 +0005t
J
* Mean + s.e.
t Significant difference between leukaemic cells and normal periphleral-
blood lymphocytes (P < 0-01).
there are any correlations between these 1975; Ellis et al., 1978). Among them, the
groups and clinical andlaboratoryfindings, terminal deoxynucleotidyl transferase
response to treatment and prognosis assay has proved to be invaluable in
(Gralnick et al., 1977; McCaffrey et al., distinguishing ALL from AML (McCaffrey
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et al., 1975; Gordon et al., 1978; Janossy
et al., 1980). A definite diagnosis into these
2 broad categories is important for
urgent treatment or further classification.
In spite of its high reliability, however, it
is not always practical due to highly
elaborate procedures. Alternatively,
several laboratories have reported success-
ful production of heterologous antisera
(Greaves & Janossy, 1978). But absorption
of nonspecific reactants in such sera is
essential, to make such antisera specific for
neoplastic cells, though it is a formidable
task.
Present methods of measuring IFP with
FDA seem to be useful, at least for the
differentiation of myelogenous and lym-
phoblastic leukaemias, AMLhaving appar-
ently about 5000 higher P value than ALL.
Two groups showed little overlapping in
P (Table I, Fig. 2A, Fig. 4). Furthermore,
our results indicate the interesting fact
that the IFPs of various types ofchronic
acute leukaemias corresponding to either
myelogenous or lymphocytic lineages (Fig.
4A-C). Therefore it is tempting to specu-
late that the observed difference in IFP
reflects the intrinsic biological properties
of the respective cells, which are deter-
mined at an early stage of haematological
differentiation and are retained during the
course of differentiation.
Cercek & Cercek (1977) have reported
that P values oflymphocytes from leukae-
mic patients were reduced in CML, CMML
(chronic myelomonocytic leukaemia),
AML and CLL. It is not clear, however,
what percentage ofleukaemic or primitive
cells was used. Since the purpose of their
work was to investigate the response of
lymphocytes, but not of leukaemic cells,
to PHA or so-called cancer basic protein,
the P value could represent primarily that
of normal lymphocytes of the patients.
In our assay, peripheral mononuclear
cells, primarily consisting of leukaemic
cells, were used (Table I). Thus, P value
in this report represents that of leukaemic
cells. A few cases (Nos. 1*, 5, 20, 23*)
with mostly normal mononuclear cells,
showed results concordant with Cercek &
Cercek (1977), including exceptionally
low P in AML. It is anticipated, on the
basis of the above result, that the cells to
be subjected to the present analysis
should contain at least 5000 leukaemic
cells in the population for a reliable assay.
IFP measured with FDA represents the
rotational Brownian motion of fluorescein
molecules in cells, thus it may indicate the
intracellular fluidity. However, this value
is possibly influenced by interaction of
fluorescein and intracellular binding pro-
tein (Epstein et al., 1977; Udkoff &
Norman, 1979), local pH, altered fluores-
cence decay time, hydrophobicity and,
most likely, fluidity of the microenviron-
ment where the probe (fluorescein) exists.
We investigated the possible presence of
fluorescein-binding protein, particularly in
myelogenousleukaemiccells,whichshowed
higher P than lymphoblastoid cells. How-
ever, experiments with the 2 cell types
exhibited similar results and little evidence
ofbinding proteins (not shown) as revealed
by a Sephadex dye-binding experiment
(Hummel & Dreyer, 1962; Maeda et al.,
1969) and by fluorescence polarization,
which measured fluorescein-protein inter-
action (Brodrick et al., 1980).
Secondly we examined the intracellular
pH, a factor known to influence the P
value of fluorescein, of representative
leukaemic cells as well as of 4 different
cell lines, based on spectroscopy (Thomas
et al., 1979). There was only a slight dif-
ference in the intracellular pH (6.0-6.7),
which would do very little to change P
(data not shown, < 5%). Therefore the
difference of P values between the cell
types appears most likely to result from
the difference in the intrinsic intracellular
fluidity ofeach cell lineage.
In addition to P value, myeloid leukae-
mic cells showed more rapid uptake of
FDA than lymphoid cells (Table I, Fig.
2B, Fig. 3A, B). This uptake velocity
represents the rate of penetration of FDA
into the cytosol, as well as the rate of
enzymatic hydrolysis of FDA into fluores-
cein (esterase activity). However, it is not
clear whether FDA transport or esterase
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activity is more responsible for this fact.
Since myeloid cells are generally larger
than lymphoid leukaemic cells, the higher
uptake velocity of the former is a logical
consequence. None the less, this difference
of FDA uptake could be used as another
parameter for the differentiation between
these 2 leukaemias. As the P value is
independent of concentration of fluoro-
chrome (as shown in Perrin's equation;
see footnote*), the difference in the
fluorescence intensity is not the cause of
the difference in P. Since the fluorescence
yielding P is observed primarily in the
cytosol and nucleus (Fig. 1) but not on the
membrane, the measured P can be regar-
ded as that of cytosol (including micro-
somes) and nucleus as well.
P probed by DPH has been measured to
discriminate between normal and malig-
nant lymphocytes. Inbar, Shinitzky and
co-workers have reported a marked in-
crease in the fluidity ofplasma-membrane
lipid of malignant lymphoid cells over
normal lymphocytes (Inbar et al., 1974;
Shinitzky & Inbar, 1974; Petitou et al.,
1978). This difference in apparent micro-
viscosity is ascribed mainly to a lowered
cholesterol/phospholipid ratio in the leu-
kaemic cells (Shinitzky & Inbar, 1974;
Petitou et al., 1978). In addition, the ratio
of saturated to unsaturated fatty acid is
also known to involve the membrane
viscosity (Yamane & Tomioka, 1979).
Blecher & Bisby (1977) extended this
method to various types of human
leukaemia. The data obtained in the
present study are in accordance with those
of Inbar and Blecher (Table II). Further-
more, similar results were found with AML
cells in the present investigation. Contrary
to the fluorescence polarization method
using FDA, however, the use of DPH
yielded no significant differences among
types of cell. This indicates that the mem-
brane fluidity or DPH-binding lipid com-
ponents in cells, but not the intracellular
fluidity, differs very little among the
different cell types.
The advantage of the present method is
simplicity, rapidity (about 2 h in total)
and considerable sensitivity, requiring
usually < 5 ml of peripheral blood. This
method appears to be invaluable to the
upgrading of the above-mentioned differ-
ential diagnosis of leukaemias, when used
in combination with recently developed
methods with membrane and enzyme
markers.
The authors thank their colleagues of the Central,
National and Red Cross Hospitals of Kumamoto, as
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